Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook

Steroid-sensitive nephrotic syndrome often follows a relapsing course with a substantial number of patients requiring cytotoxic therapy with cyclophosphamide (CP). However, the long-term success of CP treatment is difficult to predict. We retrospectively evaluated 106 patients after CP to identify p...

Ausführliche Beschreibung